These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9239777)

  • 1. Immunity to Haemophilus influenzae type b after reimmunization with oligosaccharide CRM197 conjugate vaccine in children with human immunodeficiency virus infection.
    Peters VB; Sood SK
    Pediatr Infect Dis J; 1997 Jul; 16(7):711-3. PubMed ID: 9239777
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM197 conjugate vaccine in infants with human immunodeficiency virus infection.
    Peters VB; Sood SK
    J Pediatr; 1996 Mar; 128(3):363-5. PubMed ID: 8774505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae serotype b vaccine failure: what is the significance of antibody levels?
    Spanjaard L; Rijkers GT
    Clin Infect Dis; 2009 Aug; 49(3):381-2. PubMed ID: 19580417
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.
    Granoff DM; McHugh YE; Raff HV; Mokatrin AS; Van Nest GA
    Infect Immun; 1997 May; 65(5):1710-5. PubMed ID: 9125551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine.
    Peters VB; Sood SK
    J Pediatr; 1994 Jul; 125(1):74-7. PubMed ID: 8021791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F; Paéz A; Arista A; Salmón L; Montaño L
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group.
    Read JS; Frasch CE; Rich K; Fitzgerald GA; Clemens JD; Pitt J; Pelton SI; Hanson IC; Handelsman E; Diaz C; Fowler MG
    Pediatr Infect Dis J; 1998 May; 17(5):391-7. PubMed ID: 9613652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
    Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
    Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant.
    Mariotti S; Teloni R; von Hunolstein C; Romagnoli G; Orefici G; Nisini R
    Vaccine; 2002 May; 20(17-18):2229-39. PubMed ID: 12009277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human B-lymphocyte response to Haemophilus influenzae type b capsular polysaccharide coupled to protein.
    Barington T
    APMIS Suppl; 1995; 56():1-40. PubMed ID: 8546878
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy.
    Melvin AJ; Mohan KM
    Pediatrics; 2003 Jun; 111(6 Pt 1):e641-4. PubMed ID: 12777579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response.
    Dockrell DH; Poland GA; Steckelberg JM; Wollan PC; Strickland SR; Pomeroy C
    Vaccine; 1999 Jul; 17(22):2779-85. PubMed ID: 10438047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
    Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
    N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.